Liquid-State Fermented <i>Ganoderma lucidum</i> GANO99 Regulates Gut Microbiota and Concomitantly Modulates the Behavioral Deficits and Neurohistopathological Hallmarks of Alzheimer’s Disease in a Preclinical Transgenic Mouse Model of Alzheimer’s Disease

<div>Differential microbial species in AD mice administered with the liquid-state fermented products of <i>G. lucidum</i> GANO99. (a) UpSet plot assay. (b) Biomarker compares abundance in different experimental groups by LEfSe assay. (c) Relative abundance (significant difference) of the gut microbiota in AD mice.</div>

Journal of Food Biochemistry

fig8

Figure 8

Figure 8: Liquid-State Fermented <i>Ganoderma lucidum</i> GANO99 Regulates Gut Microbiota and Concomitantly Modulates the Behavioral Deficits and Neurohistopathological Hallmarks of Alzheimer’s Disease in a Preclinical Transgenic Mouse Model of Alzheimer’s Disease 

Figure 8 | Liquid-State Fermented Ganoderma lucidum GANO99 Regulates Gut Microbiota and Concomitantly Modulates the Behavioral Deficits and Neurohistopathological Hallmarks of Alzheimer’s Disease in a Preclinical Transgenic Mouse Model of Alzheimer’s Disease 